These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25639759)

  • 1. Pretreatment Dysphagia Inventory and videofluorographic swallowing study as prognostic indicators of early survival outcomes in head and neck cancer.
    Yang CJ; Roh JL; Choi KH; Kim MJ; Choi SH; Nam SY; Kim SY
    Cancer; 2015 May; 121(10):1588-98. PubMed ID: 25639759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
    Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
    Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
    Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
    Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?
    Hutcheson KA; Barrow MP; Lisec A; Barringer DA; Gries K; Lewin JS
    Laryngoscope; 2016 May; 126(5):1108-13. PubMed ID: 26542529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between swallow-specific quality of life and fiber-optic endoscopic evaluation of swallowing findings in patients with head and neck cancer.
    Florie M; Baijens L; Kremer B; Kross K; Lacko M; Verhees F; Winkens B
    Head Neck; 2016 Apr; 38 Suppl 1():E1848-56. PubMed ID: 26695518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function.
    Strüder D; Ebert J; Kalle F; Schraven SP; Eichhorst L; Mlynski R; Großmann W
    Curr Oncol; 2023 Dec; 30(12):10336-10350. PubMed ID: 38132387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swallowing outcome measures in head and neck cancer--How do they compare?
    Pedersen A; Wilson J; McColl E; Carding P; Patterson J
    Oral Oncol; 2016 Jan; 52():104-8. PubMed ID: 26564310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment.
    Starmer HM; Tippett D; Webster K; Quon H; Jones B; Hardy S; Gourin CG
    Head Neck; 2014 Oct; 36(10):1392-7. PubMed ID: 24038454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
    Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer.
    Frowen J; Cotton S; Corry J; Perry A
    Head Neck; 2010 Apr; 32(4):513-28. PubMed ID: 19691115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 19. Subjective and perceptive assessment of speech/voice and swallowing function before and after radiation therapy in patients of head-and-neck squamous cell cancer.
    Aggarwal VV; Waghmare CM; Lolage SN; Pawar HJ; Ravichandran M; Bhanu A
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
    Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
    Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.